BDTB on OTC
Bodhi Tree Biotechnology Inc
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Wenyuan Group Corp., Hestia Insight Inc. or SATIVUS TECH CORP., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs88¢$14.9K
- Income tax12¢$2.0K
Out of $17.0K in revenue.2 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2025-09-30 |
|---|---|
| Service revenue | $17.0K |
| General and administrative expenses | $164.6K |
| Loss from operation | -$147.6K |
| Loss before provision for income taxes | -$147.6K |
| Interest income | $2 |
| Total other income | $2 |
| Loss before income taxes | -$147.6K |
| Provision for income taxes | $2.0K |
| Net Loss | -$149.7K |
| Basic loss per common share | -$0.01 |
| Diluted loss per common share | -$0.01 |
| Basic weighted average number of common shares used in per share | 25.4M shares |
| Diluted weighted average number of common shares used in per share | 25.4M shares |
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2025-09-30 | 2024-09-30 |
|---|---|---|
| Cash | $109.4K | $259.6K |
| Prepaid Expenses | $9.8K | $9.8K |
| Total assets | $119.2K | $269.3K |
| Due to related party | $500 | |
| Total current liabilities | $500 | |
| Total liabilities | $500 | |
| Common stock, $0.0001 par value, 320,000,000 shares authorized, 25,441,042 shares issued and outstanding as of September 30, 2025 and 2024 | $2.5K | $2.5K |
| Additional Paid in Capital | $328.2K | $328.2K |
| Accumulated deficit | -$211.6K | -$62.0K |
| Total stockholders equity | $119.2K | $268.8K |
| Total liabilities and stockholders equity | $119.2K | $269.3K |
| Preferred stock, par value | $0.00 | $0.00 |
| Preferred stock, shares authorized | 30.0M shares | 30.0M shares |
| Preferred stock, shares issued | 0 shares | 0 shares |
| Preferred stock, shares outstanding | 0 shares | 0 shares |
| Common stock, par value | $0.00 | $0.00 |
| Common stock, shares authorized | 320.0M shares | 320.0M shares |
| Common stock, shares issued | 25.4M shares | 25.4M shares |
| Common stock, shares outstanding | 25.4M shares | 25.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2025-09-30 |
|---|---|
| Net loss | -$149.7K |
| (Decrease) / Increase in Due to related party | -$500 |
| Net cash used in operating activities | -$150.2K |
| Net change in cash | -$150.2K |
| Cash Paid in Income tax | $2.0K |
Recent filings
- Aug 14, 202610-Q
- May 14, 202610-Q
- Feb 13, 202610-Q
- Dec 29, 202510-K
- Aug 12, 202510-Q
- Jul 28, 202510-Q/A
- Jun 6, 20258-K
- Jun 5, 2025D/A
- May 20, 202510-Q
- May 14, 2025NT 10-Q
- Apr 15, 2025D
- Mar 4, 2025424B3
- Mar 3, 2025EFFECT
- Feb 27, 2025CORRESP
- Feb 21, 2025S-1/A
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6